Streetbeat News

CLOV

Clover Health Investments, Corp.

https://www.cloverhealth.com

Industry

Medical - Healthcare Plans

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Open

2.99

Mkt cap

1.6B

Volume

4.4M

High

3.12

P/E Ratio

-16.37

52-wk high

4.71

Low

2.97

Div yield

N/A

52-wk low

0.61

Clover Health Investments is making financial progress in 2024 with innovative Medicare Advantage plans and technology-driven healthcare solutions. The company achieved a 4.0 rating for its PPO plan, indicating improved quality of care and potential for higher CMS reimbursements. Despite a slight membership decline, net income losses have decreased significantly from 2022 to 2024.

Portfolio Pulse from

December 11, 2024 | 12:30 pm

Clover Health Investments (CLOV) has formed a hammer chart pattern, suggesting support and potential trend reversal. Upward earnings estimate revisions further support a positive outlook.

Portfolio Pulse from

December 05, 2024 | 4:00 pm

Clover Health's stock has dipped 32% after Q3 earnings, presenting a potential buying opportunity. The company is improving its financial performance and has received a 4-star rating upgrade for 2026, which could boost market share and secure more deals.

Portfolio Pulse from

November 18, 2024 | 5:00 pm

Clover Health Investments (CLOV) has seen a significant drop of 26.32% over the past four weeks, making it technically oversold. This suggests a potential exhaustion of selling pressure. Additionally, Wall Street analysts are revising earnings estimates higher, indicating a possible trend reversal for CLOV in the near term.

Portfolio Pulse from

November 15, 2024 | 4:00 pm

Clover Health Investments (CLOV) has experienced a significant decline of 25.82% over the past four weeks. However, the stock is now in oversold territory, and Wall Street analysts are revising earnings estimates higher, suggesting a potential trend reversal.

Portfolio Pulse from

November 14, 2024 | 3:45 pm

Clover Health Investments (CLOV) has formed a hammer chart pattern, suggesting support and potential trend reversal. Upward earnings estimate revisions further support a positive outlook.

Portfolio Pulse from

November 12, 2024 | 4:15 pm

Clover Health's third-quarter 2024 results showed strong performance, beating earnings expectations. However, despite this positive outcome, the stock declined as the company revised its fiscal year 2024 outlook.

Portfolio Pulse from

November 07, 2024 | 5:30 pm

Clover Health Investments, Corp. (CLOV) reported a Q3 loss of $0.02 per share, which was better than the Zacks Consensus Estimate of a $0.03 loss. This is an improvement from the $0.09 loss per share reported a year ago.

Portfolio Pulse from

November 07, 2024 | 12:45 am

Clover Health Investments, Corp. (CLOV) held its Q3 2024 earnings call, discussing financial performance and company updates.

Portfolio Pulse from

November 07, 2024 | 12:00 am

Clover Health's strategic shift towards profitability, marked by the divestiture of its non-insurance segment, has resulted in improved earnings. The launch of the Counterpart Health platform aims to diversify revenue streams, mitigating risks from declining Medicare Advantage memberships. The company maintains a strong balance sheet with no long-term debt.

Portfolio Pulse from

November 06, 2024 | 9:00 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.